OpenDock:一个基于pytorch的开源框架,用于蛋白质-连接体对接和建模
Qiuyue Hu1,2, Zechen Wang3, Jintao Meng1
1Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518000, China.
Bioinformatics (Oxford, England)
|October 21, 2024
概括
OpenDock是一个新的基于Python的分子对接框架,增强了药物设计和酶工程的灵活性和用户友好性. 它支持各种各样的评分功能和采样策略,改进计算建模.
科学领域:
- 计算化学是一种计算化学.
- 生物信息学是一种生物信息学.
- 药物发现 药物发现
背景情况:
- 分子对接对于药物设计和酶工程至关重要.
- 现有的工具缺乏灵活性和用户友好性,阻碍了开发和验证.
- 在当前的框架中,实施先进的采样和评分功能是具有挑战性的.
研究的目的:
- 开发一个灵活的,用户友好的,开源的分子对接框架.
- 为了促进各种分数函数的集成和验证.
- 为了实现分子建模的先进采样策略.
主要方法:
- 使用Python和PyTorch开发了OpenDock.
- 集成支持多个评分功能,用于对接和后处理.
- 实施模拟回火和蒙特卡洛优化采样.
- 启用了遗传算法和粒子群优化的扩展.
- 集成的距离限制用于共价和受限制的对接.
主要成果:
- OpenDock为分子对接提供了一个灵活和可扩展的平台.
- 支持整合各种分数功能,以提高准确性.
- 提供多种采样方法,包括模拟回火和蒙特卡洛.
- 方便共振对接和远距离引导的姿势采样.
- 在蛋白质 - 配体建模任务中表现出显著的灵活性.
结论:
- OpenDock解决了现有的分子对接工具的局限性.
- 为计算机辅助药物设计和酶工程提供了一个多功能框架.
- 提高了计算建模任务的灵活性和开发方便性.
相关概念视频
Ligand Binding Sites
12.7K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.7K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Molecular Models
38.0K
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
38.0K
Protein-Protein Interfaces
3.7K
3.7K
Protein-Drug Binding: Mechanism and Kinetics
323
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
323


